Co-Authors
This is a "connection" page, showing publications co-authored by Andreas Kremer and Marcel Vetter.
Connection Strength
1.523
-
Purple urine in a patient after recovery from a SARS-CoV-2 infection. Int J Infect Dis. 2021 04; 105:472-473.
Score: 0.931
-
Successful treatment of COVID-19 infection with convalescent plasma in B-cell-depleted patients may promote cellular immunity. Eur J Immunol. 2021 10; 51(10):2478-2484.
Score: 0.241
-
Correction to: Diagnostic performance of four SARS-CoV-2 antibody assays in patients with COVID-19 or with bacterial and non-SARS-CoV-2 viral respiratory infections. Eur J Clin Microbiol Infect Dis. 2021 Sep; 40(9):1999-2004.
Score: 0.060
-
Diagnostic performance of four SARS-CoV-2 antibody assays in patients with COVID-19 or with bacterial and non-SARS-CoV-2 viral respiratory infections. Eur J Clin Microbiol Infect Dis. 2021 Sep; 40(9):1983-1997.
Score: 0.059
-
Lack of antibodies against seasonal coronavirus OC43 nucleocapsid protein identifies patients at risk of critical COVID-19. J Clin Virol. 2021 06; 139:104847.
Score: 0.059
-
Upregulation of CCR4 in activated CD8+ T cells indicates enhanced lung homing in patients with severe acute SARS-CoV-2 infection. Eur J Immunol. 2021 06; 51(6):1436-1448.
Score: 0.059
-
Interleukin-3 is a predictive marker for severity and outcome during SARS-CoV-2 infections. Nat Commun. 2021 02 18; 12(1):1112.
Score: 0.058
-
Glucocorticoid-induced relapse of COVID-19 in a patient with sarcoidosis. Ann Rheum Dis. 2020 Jun 30.
Score: 0.056